These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7589471)

  • 1. N-glycosylation-defective receptor for erythropoietin can transduce the ligand-induced cell proliferation signal.
    Nagao M; Morishita E; Hanai Y; Kobayashi K; Sasaki R
    FEBS Lett; 1995 Oct; 373(3):225-8. PubMed ID: 7589471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
    Hamadmad SN; Hohl RJ
    Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
    Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
    Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of artificially introduced N-glycosylation sites on the in vitro activity of Xenopus laevis erythropoietin.
    Nagasawa K; Meguro M; Sato K; Tanizaki Y; Nogawa-Kosaka N; Kato T
    PLoS One; 2015; 10(4):e0124676. PubMed ID: 25898205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
    Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
    Arcasoy MO; Karayal AF
    Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation.
    Sawyer ST; Hankins WD
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6849-53. PubMed ID: 8341708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
    Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M; Gross AW; Lodish HF
    Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
    Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
    Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of three erythropoietin (Epo)-binding proteins in various human Epo-responsive cell lines and in cells transfected with human Epo-receptor cDNA.
    Takahashi T; Chiba S; Hirano N; Yazaki Y; Hirai H
    Blood; 1995 Jan; 85(1):106-14. PubMed ID: 7803787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tunicamycin treatment on ligand binding to the erythropoietin receptor: conversion from two classes of binding sites to a single class.
    Nagao M; Matsumoto S; Masuda S; Sasaki R
    Blood; 1993 May; 81(10):2503-10. PubMed ID: 8490167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subunit structure of the erythropoietin receptor analyzed by 125I-Epo cross-linking in cells expressing wild-type or mutant receptors.
    Miura O; Ihle JN
    Blood; 1993 Apr; 81(7):1739-44. PubMed ID: 8461460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.
    Wu P; Zhang N; Wang X; Zhang C; Li T; Ning X; Gong K
    PLoS One; 2012; 7(9):e45122. PubMed ID: 23028796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization.
    Watowich SS; Hilton DJ; Lodish HF
    Mol Cell Biol; 1994 Jun; 14(6):3535-49. PubMed ID: 8196600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
    Luo K; Lodish HF
    EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor.
    Jubinsky PT; Krijanovski OI; Nathan DG; Tavernier J; Sieff CA
    Blood; 1997 Sep; 90(5):1867-73. PubMed ID: 9292519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.
    Singh S; Verma R; Pradeep A; Leu K; Mortensen RB; Young PR; Oyasu M; Schatz PJ; Green JM; Wojchowski DM
    PLoS One; 2012; 7(1):e29064. PubMed ID: 22253704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
    Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
    Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.